JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
951
Exelon
EXC
$42B
| $42.8M | 0.01% |
1,654,256
+190,042
| +13% | +$5.05M |
2013 Q2
28 quarters
|
|
952
CALL
NVIDIA
NVDA
$5.65T
| $42.8M | 0.01% |
4,504,000
-32,428,000
| -88% | -$262M |
2018 Q1
9 quarters
|
|
|
VIE
953
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $42.7M | 0.01% |
986,636
+128,517
| +15% | +$5.82M |
2019 Q4
2 quarters
|
|
954
American Airlines Group
AAL
$8.57B
| $42.6M | 0.01% |
3,258,660
+2,835,599
| +670% | +$34.4M |
2013 Q4
26 quarters
|
|
955
CGI
GIB
$14.5B
| $42.6M | 0.01% |
675,511
-432,069
| -39% | -$26.9M |
2015 Q1
21 quarters
|
|
956
Cardlytics
CDLX
$14.9M
| $42.5M | 0.01% |
60,769
+24,984
| +70% | +$14.4M |
2018 Q1
9 quarters
|
|
957
Adaptive Biotechnologies
ADPT
$4.52B
| $42.5M | 0.01% |
878,873
+203,753
| +30% | +$7.43M |
2019 Q2
4 quarters
|
|
958
Aptiv
APTV
$9.04B
| $42.2M | 0.01% |
541,578
+281,660
| +108% | +$19.4M |
2013 Q2
28 quarters
|
|
959
Floor & Decor
FND
$4.84B
| $42.2M | 0.01% |
731,584
+669,423
| +1,077% | +$30.5M |
2017 Q2
12 quarters
|
|
960
Commercial Metals
CMC
$7.03B
| $42.1M | 0.01% |
2,063,347
-204,593
| -9% | -$3.51M |
2013 Q2
28 quarters
|
|
|
CXP
961
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $42.1M | 0.01% |
3,202,962
+670,535
| +26% | +$8.83M |
2014 Q2
24 quarters
|
|
962
Q32 Bio
QTTB
$245M
| $42.1M | 0.01% |
153,909
+25,919
| +20% | +$6.91M |
2018 Q1
9 quarters
|
|
963
PUT
3M
MMM
$83.5B
| $41.8M | 0.01% |
320,408
-33,608
| -9% | -$4.23M |
2016 Q2
16 quarters
|
|
964
Heron Therapeutics
HRTX
$66M
| $41.7M | 0.01% |
2,837,407
+259,665
| +10% | +$4.27M |
2015 Q3
19 quarters
|
|
|
HOLX
965
DELISTED
Hologic
HOLX
| $41.5M | 0.01% |
727,978
+89,171
| +14% | +$4.38M |
2013 Q2
28 quarters
|
|
966
Ameren
AEE
$27.7B
| $41.4M | 0.01% |
587,900
-1,172,329
| -67% | -$85M |
2013 Q2
28 quarters
|
|
967
Roku
ROKU
$22.6B
| $41.3M | 0.01% |
354,179
-568,417
| -62% | -$65M |
2018 Q1
9 quarters
|
|
968
NRG Energy
NRG
$20B
| $41.2M | 0.01% |
1,266,650
+26,479
| +2% | +$872K |
2013 Q2
28 quarters
|
|
969
International Paper
IP
$16.9B
| $41.2M | 0.01% |
1,234,735
+362,104
| +41% | +$11.5M |
2013 Q2
28 quarters
|
|
970
PUT
Gilead Sciences
GILD
$179B
| $41.2M | 0.01% |
535,000
-92,300
| -15% | -$7.07M |
2013 Q2
28 quarters
|
|
|
CERN
971
DELISTED
Cerner Corp
CERN
| $41.1M | 0.01% |
599,186
-323,685
| -35% | -$22.2M |
2013 Q2
28 quarters
|
|
972
Broadridge
BR
$17.7B
| $41M | 0.01% |
324,969
+35,545
| +12% | +$4.12M |
2013 Q2
28 quarters
|
|
|
NEE.PRO
973
DELISTED
NextEra Energy, Inc. 4.872% Corporate Units
NEE.PRO
| $40.9M | 0.01% |
842,494
-55,617
| -6% | -$2.72M |
2019 Q3
3 quarters
|
|
974
iShares Global Tech ETF
IXN
$9.99B
| $40.9M | 0.01% |
1,041,264
+668,898
| +180% | +$23.7M |
2015 Q4
18 quarters
|
|
975
Open Text
OTEX
$5.38B
| $40.9M | 0.01% |
961,839
+215,255
| +29% | +$8.53M |
2015 Q4
18 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.